Six-month, prospective, longitudinal, open-Label caffeine and dextromethorphan phenotyping study in children with growth hormone deficiency receiving recombinant human growth hormone replacement

Mary Jayne Kennedy(High Point University), Gregory L. Kearns(Children's Mercy Hospital), Andrea Gaedigk(University of North Carolina at Chapel Hill), Ned B. Smith(University of Louisville), Daniel A. Davis(University of Louisville), Robin E. Pearce(Children's Mercy Hospital)
Clinical Therapeutics
September 1, 2008
Cited by 7


Related Papers